Drug Injection Devices to 2028

injectable drugs deepdive  Drug Injection Devices to 2028 • JDD307F• April 2022 • US$4,850



The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions. Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process.


  Order Online

Drug Injection Devices to 2028 – What You Will Learn

• What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?
• What are the market drivers influencing syringe and injector device designs, feature/functionality, product branding, competing technologies and commercial development?
• What are the key characteristics of the major injection device market segments and what is the impact of market demographics, and competing business strategies?
• What is the current market for syringe and injector demand by indication and therapy and what will it be in 2028?
• Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
• What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?


Drug Injection Devices to 2028 – Summary of Contents

Executive Summary

The Market Opportunity

Injectable Drug Demand Drivers

Syringe Economics

Drug Self-injection – Device Technology Factors

Device Selection – Stability and Material Issues

Competitive Landscape

Injection Device Suppliers Capabilities and Market Presence

      North America



Commercial Injection Device Classes – Strategic Analysis


   Manual Injection Autoinjectors

   Disposable Autoinjectors

   Reusable Autoinjectors

   Fixed Dose Autoinjectors

   Fixed Dose/Reusable Injectors

   Variable Dose Autoinjectors

   Syringe-based Autoinjectors

   Cartridge Base Autoinjectors

   Automated Injection Autoinjectors

   Product Specific Autoinjectors

Dual Chamber Devices

   Dual Chamber Syringes

   Dual Chamber Pen Injectors

Needle-free Injectors

Pen Injectors

   Standardized Pen Platforms

   Pen Classes

   Reusable Pens

   Disposable Pens


Drug/Device Combination Products

Prefilled Syringes

   Glass Prefilled Syringes

   COC Prefilled Syringes

Subcutaneous Infusion Devices


Injection Device Selection Criteria

Fixed vs Variable Dose Devices

Lyophilized Drugs/Reconstitution

Needle Configuration Strategies

Disposable Drug Cartridges

Human Engineering/Ergonomics

Branding/Private Labeling


Drug Injection Device Market Segment Analysis & Forecasts



Autoimmune Diseases

Rheumatoid Arthritis


Stelara (Ustekinumab)

Multiple Sclerosis

Emergency Medicine


Hormone Replacement


Reproductive Health



Injectable Drug Therapeutics – Market Factors

Regulatory Issues

Device Branding

Patient Compliance and Ease of Use

Healthcare Economics

Company Profiles